{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05538130",
            "orgStudyIdInfo": {
                "id": "C4901001"
            },
            "organization": {
                "fullName": "Pfizer",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors",
            "officialTitle": "A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-study-to-learn-about-the-study-medicine-called-pf-in-people-with-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-11-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-09-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-09",
            "studyFirstSubmitQcDate": "2022-09-09",
            "studyFirstPostDateStruct": {
                "date": "2022-09-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-31",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Pfizer",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) administered as a single agent and in combination with other study medications in people with solid tumors. This study is seeking participants who have an advanced solid tumor for which the available treatments are no longer effective in controlling their cancer. All participants in this study will receive PF-07799544. PF-07799544 comes as a tablet to take by mouth daily (initially 2 times per day, but this could change to once daily or another frequency). Depending on the part of the study, participants may also receive another study medicine.\n\n* In the first part of the study, people with melanoma or other solid tumors may also receive encorafenib. Encorafenib comes as a capsule and is taken once per day.\n* In the second part of the study, people with melanoma or other cancers with abnormalities in a gene called \"BRAF\" will receive PF-07799544 with other study medicines (for example, PF-07799933).\n\nParticipants may receive the study medicines for about 2 years. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic."
        },
        "conditionsModule": {
            "conditions": [
                "Melanoma",
                "Glioma",
                "Thyroid Cancer",
                "Non-Small Cell Lung Cancer",
                "Malignant Neoplasms",
                "Brain Neoplasms",
                "Colorectal Cancer"
            ],
            "keywords": [
                "Proto-Oncogene Proteins B-raf",
                "Brain neoplasms",
                "Melanoma",
                "Carcinoma, Non-Small-Cell Lung",
                "Neoplasm by Histologic Type",
                "CRC",
                "MAPK"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 124,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Monotherapy Dose Escalation (Phase 1a)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive PF-07799544",
                    "interventionNames": [
                        "Drug: PF-07799544",
                        "Drug: encorafenib"
                    ]
                },
                {
                    "label": "Phase 1b Substudy B Combination Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive PF-07799544 and PF-07799933",
                    "interventionNames": [
                        "Drug: PF-07799544",
                        "Drug: PF-07799933"
                    ]
                },
                {
                    "label": "Phase 1b Substudy B Combination Dose Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive PF-07799544 and PF-07799933",
                    "interventionNames": [
                        "Drug: PF-07799544",
                        "Drug: PF-07799933"
                    ]
                },
                {
                    "label": "Phase 1b Substudy C Combination Dose Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive PF-07799544 and PF-07799933",
                    "interventionNames": [
                        "Drug: PF-07799544",
                        "Drug: PF-07799933"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "PF-07799544",
                    "description": "Tablet",
                    "armGroupLabels": [
                        "Monotherapy Dose Escalation (Phase 1a)",
                        "Phase 1b Substudy B Combination Dose Escalation",
                        "Phase 1b Substudy B Combination Dose Expansion",
                        "Phase 1b Substudy C Combination Dose Expansion"
                    ],
                    "otherNames": [
                        "ARRY-134"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "PF-07799933",
                    "description": "Tablet",
                    "armGroupLabels": [
                        "Phase 1b Substudy B Combination Dose Escalation",
                        "Phase 1b Substudy B Combination Dose Expansion",
                        "Phase 1b Substudy C Combination Dose Expansion"
                    ],
                    "otherNames": [
                        "ARRY-440"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "encorafenib",
                    "description": "Capsule",
                    "armGroupLabels": [
                        "Monotherapy Dose Escalation (Phase 1a)"
                    ],
                    "otherNames": [
                        "BRAFTOVI"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with dose limiting toxicities (DLTs) Phase 1a monotherapy and Phase 1b combination therapy dose escalation",
                    "description": "DLTs will be evaluated during the first cycle (21 days) as a single agent (phase 1a monotherapy) or in combination with other agents (phase 1b dose escalation)",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "Overall response rate (ORR) (phase 1b expansion)",
                    "description": "Response will be evaluated via radiographical tumor assessments by Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1)",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "Number of participants with treatment-emergent adverse events (AEs) (phase 1a and 1b dose escalation phases)",
                    "description": "AEs as characterized by type, frequency, severity, timing, seriousness, and relationship to study therapy",
                    "timeFrame": "Baseline to 28 days after last dose of study medication"
                },
                {
                    "measure": "Number of participants with clinically significant change from baseline in laboratory abnormalities (phase 1a and phase 1b dose escalation phase)",
                    "description": "Laboratory abnormalities as characterized by type, frequency, severity, and timing.",
                    "timeFrame": "Baseline to 28 days after last dose of study treatment"
                },
                {
                    "measure": "Number of participants with clinically significant change from baseline in vital sign abnormalities (phase 1a and phase 1b dose escalation phase)",
                    "description": "Vital sign abnormalities as characterized by type, frequency, severity, and timing.",
                    "timeFrame": "Baseline to 28 days after last dose of study treatment"
                },
                {
                    "measure": "Number of participants with clinically significant change from baseline in physical exam abnormalities (phase 1a and phase 1b dose escalation phase)",
                    "description": "Physical exam abnormalities as as graded by National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.",
                    "timeFrame": "Baseline to 28 days after last dose of study treatment"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants with treatment-emergent adverse events (AEs)",
                    "description": "AEs as characterized by type, frequency, severity, timing, seriousness, and relationship to study therapy",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "Number of participants with clinically significant change from baseline in laboratory abnormalities",
                    "description": "Laboratory abnormalities as characterized by type, frequency, severity, and timing.",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "Number of participants with clinically significant change from baseline in vital sign abnormalities",
                    "description": "Vital sign abnormalities as characterized by type, frequency, severity, and timing.",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, maximum observed concentration (Cmax)",
                    "description": "PK parameters of PF-07799544, Single dose, Cmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, time to maximum plasma concentration (Tmax)",
                    "description": "PK parameters of PF-07799544, Single dose, Tmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, area under the plasma concentration-time curve from time 0 to the last time point of quantifiable concentration (AUClast)",
                    "description": "PK parameters of PF-07799544, Single dose, AUClast",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, area under the plasma concentration-time curve from time 0 extrapolated to infinity (AUCinf)",
                    "description": "PK parameters of PF-07799544, Single dose, AUCinf",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, terminal elimination half life (t\u00bd)",
                    "description": "PK parameters of PF-07799544, Single dose, t\u00bd",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, apparent oral clearance (CL/F)",
                    "description": "PK parameters of PF-07799544, Single dose, CL/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Single dose, apparent volume of distribution (Vz/F)",
                    "description": "PK parameters of PF-07799544, Single dose, Vz/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, maximum observed concentration (Cmax)",
                    "description": "PK parameters of PF-07799544, Multiple dose, Cmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, time to maximum plasma concentration (Tmax)",
                    "description": "PK parameters of PF-07799544, Multiple dose, Tmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, area under the plasma concentration-time curve over the dosing interval (AUC\u03c4)",
                    "description": "PK parameters of PF-07799544, Multiple dose, AUC\u03c4",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, terminal elimination half life (t\u00bd)",
                    "description": "PK parameters of PF-07799544, Multiple dose, t\u00bd",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, apparent oral clearance (CL/F)",
                    "description": "PK parameters of PF-07799544, Multiple dose, CL/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799544, Multiple dose, apparent volume of distribution (Vz/F)",
                    "description": "PK parameters of PF-07799544, Multiple dose, Vz/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, maximum observed concentration (Cmax)",
                    "description": "PK parameters of PF-07799933, Single dose, Cmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, time to maximum plasma concentration (Tmax)",
                    "description": "PK parameters of PF-07799933, Single dose, Tmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, area under the plasma concentration-time curve from time 0 to the last time point of quantifiable concentration (AUClast)",
                    "description": "PK parameters of PF-07799933, Single dose, AUClast",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, area under the plasma concentration-time curve from time 0 extrapolated to infinity (AUCinf)",
                    "description": "PK parameters of PF-07799933, Single dose, AUCinf",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, terminal elimination half life (t\u00bd)",
                    "description": "PK parameters of PF-07799933, Single dose, t\u00bd",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, apparent oral clearance (CL/F)",
                    "description": "PK parameters of PF-07799933, Single dose, CL/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Single dose, apparent volume of distribution (Vz/F)",
                    "description": "PK parameters of PF-07799933, Single dose, Vz/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, maximum observed concentration (Cmax)",
                    "description": "PK parameters of PF-07799933, Multiple dose, Cmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, time to maximum plasma concentration (Tmax)",
                    "description": "PK parameters of PF-07799933, Multiple dose, Tmax",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, area under the plasma concentration-time curve over the dosing interval (AUC\u03c4)",
                    "description": "PK parameters of PF-07799933, Multiple dose, AUC\u03c4",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, terminal elimination half life (t\u00bd)",
                    "description": "PK parameters of PF-07799933, Multiple dose, t\u00bd",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, apparent oral clearance (CL/F)",
                    "description": "PK parameters of PF-07799933, Multiple dose, CL/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PK parameters of PF-07799933, Multiple dose, apparent volume of distribution (Vz/F)",
                    "description": "PK parameters of PF-07799933, Multiple dose, Vz/F",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "ORR (phase 1a and phase 1b dose escalation)",
                    "description": "ORR as assessed using the RECIST version 1.1.",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "Duration of response overall and in CNS",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "Intracranial response (phase 1b Part 2)",
                    "description": "Intracranial response by RECIST version 1.1 (for brain metastases)",
                    "timeFrame": "Baseline to 2 years"
                },
                {
                    "measure": "PFS",
                    "timeFrame": "Baseline to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of advanced/metastatic solid tumor including primary brain tumor for monotherapy phase 1a dose escalation\n* Disease progressed during/following last prior treatment and no satisfactory alternative treatment options for monotherapy phase 1a dose escalation\n* For Substudy B, histological or cytological diagnosis of advanced/metastatic melanoma\n* For Substudy C, unresectable or adv/metastatic solid tumor progressed on, or with demonstrated intolerance to SOC, excluding melanoma,\n* For Substudy B and C, measurable disease by RECIST version 1.1\n* For Substudy B, evidence of a BRAF V600 mutation or BRAF Class II/III alteration in tumor tissue and/or blood\n* For Substudy C, evidence of a BRAF founder alteration (non-V600 Class II/III BRAF alteration)\n\nExclusion Criteria:\n\n* Brain metastasis larger than 4 cm\n* History or current evidence of retinal vein occlusion (RVO) or concurrent neuromuscular disorder associated with elevated creatine kinase (CK)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "16 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "role": "CONTACT",
                    "phone": "1-800-718-1021",
                    "email": "ClinicalTrials.gov_Inquiries@pfizer.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "affiliation": "Pfizer",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Highlands Oncology Group, PA",
                    "status": "RECRUITING",
                    "city": "Fayetteville",
                    "state": "Arkansas",
                    "zip": "72703",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.06258,
                        "lon": -94.15743
                    }
                },
                {
                    "facility": "Highlands Oncology Group",
                    "status": "RECRUITING",
                    "city": "Fayetteville",
                    "state": "Arkansas",
                    "zip": "72703",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.06258,
                        "lon": -94.15743
                    }
                },
                {
                    "facility": "Highlands Oncology Group, PA",
                    "status": "RECRUITING",
                    "city": "Rogers",
                    "state": "Arkansas",
                    "zip": "72758",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.33202,
                        "lon": -94.11854
                    }
                },
                {
                    "facility": "Highlands Oncology Group",
                    "status": "RECRUITING",
                    "city": "Rogers",
                    "state": "Arkansas",
                    "zip": "72758",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.33202,
                        "lon": -94.11854
                    }
                },
                {
                    "facility": "Highlands Oncology Group, PA",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "Highlands Oncology Group",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "Highlands Oncology",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Moffitt McKinley Hospital",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Florida Eye Center at Florida Medical Clinic",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33613",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Brigitte Harris Cancer Pavilion",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Henry Ford Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Columbia University Irving Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "CUIMC Research Pharmacy",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Cleveland Clinic Taussig Cancer Center Investigational Pharmacy",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Cleveland Clinic Taussig Cancer Center",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Providence Cancer Institute Franz Clinic",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97213",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Providence Portland Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97213",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "University of Texas MD Anderson Cancer Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Fred Hutchinson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "University of Washington Medical Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98195",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                },
                {
                    "facility": "Cross Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "The Ottawa Hospital - General Campus",
                    "status": "RECRUITING",
                    "city": "Ottawa",
                    "state": "Ontario",
                    "zip": "K1H 8L6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "Sunnybrook Research Institute",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M4N 3M5",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2M9",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Jewish General Hospital",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H3T 1E2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "McGill University Health Centre",
                    "status": "RECRUITING",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H4A 3J1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Centre int\u00e9gr\u00e9 de canc\u00e9rologie du CHU de Qu\u00e9bec Universit\u00e9 Laval, H\u00f4pital de l'Enfant-J\u00e9sus",
                    "status": "RECRUITING",
                    "city": "Quebec City",
                    "state": "Quebec",
                    "zip": "G1J 1Z4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "To obtain contact information for a study center near you, click here.",
                    "url": "https://pmiform.com/clinical-trial-info-request?StudyID=C4901001"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                },
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16723",
                    "name": "Thyroid Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}